Get started
Author

Lindsay Stansfield

Observed names: L. Stansfield, Lindsay C Stansfield, Lindsay C. Stansfield, Stansfield L
Observed institutions: National Institutes of Health, Maimonides Medical Center, Mayo Clinic, Pfizer (United States), Denver Health Medical Center, Verastem (United States), National Institutes of Health Clinical Center
OpenAlex ID: A5057465795
Midostaurin: A New Oral Agent Targeting FMS ‐Like Tyrosine Kinase 3‐Mutant Acute Myeloid Leukemia
2017 · Lindsay C. Stansfield, Daniel A. Pollyea · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 22
Bosutinib
2013 · Lindsay Stansfield, Thomas E Hughes, et al. · Annals of Pharmacotherapy · 21
Cardiac Arrest With Residual Blindness After Overdose of Tessalon® (Benzonatate) Perles
2009 · Victor Cohen, Samantha P. Jellinek, et al. · Journal of Emergency Medicine · 14
The use of Novel Agents in Multiple Myeloma Patients with Hepatic Impairment
2015 · Lindsay C Stansfield, Wilson I Gonsalves, et al. · Future Oncology · 13
Biomarker Testing Trends in Patients With Metastatic Colorectal Cancer Who Live in Rural Areas and Urban Clusters in the US
2023 · Mark A Lewis, Lindsay Stansfield, et al. · The Oncologist · 7
PDF
A Survey of Drug Information References Emergency Medicine Clinicians Utilize for Prescribing in Pregnant Patients
2010 · Samantha P Jellinek, Victor Cohen, et al. · Annals of Pharmacotherapy · 6
A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD
2020 · Thomas E. Hughes, Lindsay Stansfield, et al. · Bone Marrow Transplantation · 5
Biomarker testing in patients (pts) with metastatic colorectal cancer (mCRC): Survey of U.S. oncologists (ONC) in rural areas and urban clusters.
2021 · Mark Andrew Lewis, Lindsay Stansfield, et al. · Journal of Clinical Oncology · 3
Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2− Metastatic Breast Cancer
2025 · Timothy Pluard, Rickard Sandin, et al. · ClinicoEconomics and Outcomes Research · 2
PDF
Calcium and magnesium for oxaliplatin-induced neuropathy
2014 · Lindsay Stansfield · American Journal of Health-System Pharmacy · 2
Supplementary materials: US population-level model of clinical impact of lorlatinib treatment on ALK+ metastatic non-small cell lung cancer outcomes
2026 · Adam Kasle, Devin Abrahami, et al. · Figshare
US population-level model of clinical impact of lorlatinib treatment on ALK+ metastatic non-small cell lung cancer outcomes
2026 · Adam Kasle, Devin Abrahami, et al. · Journal of Comparative Effectiveness Research
Ee253 Economic Burden of Incident Brain Metastases in Medicare Beneficiaries With Alk+ Metastatic Non-small Cell Lung Cancer
2026 · Devin Abrahami, Zachary Marcum, et al. · Value in Health
CO258 US Population-Level Clinical Impact of Lorlatinib Treatment on ALK+ Metastatic Non-Small Cell Lung Cancer Outcomes
2025 · Adam Kasle, Devin Abrahami, et al. · Value in Health
P3.12.34 Real-World Study in Patients With ALK+ Metastatic Non-Small Cell Lung Cancer (mNSCLC) Treated With First-Line (1L) Lorlatinib
2025 · S. Gadgeel, L. Stansfield, et al. · Journal of Thoracic Oncology
Biomarker testing in patients (pts) with metastatic colorectal cancer (mCRC): Perspectives from U.S. oncologists (ONC) in rural areas and urban clusters.
2022 · Mark Andrew Lewis, Lindsay Stansfield, et al. · Journal of Clinical Oncology
Works count: 17
Citation count: 95
H-index: 6
I10-index: 4
Year
Topic
Type